Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Sagimet Biosciences Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation or Carry Forward Rule	Amount Registered(1)	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price(1)(2)	Fee Rate	Amount of Registration Fee
Fees to Be Paid	Equity	Series A common stock, $0.0001 par value per share	457(o)	718,750	$16.00	$11,500,000	0.0001102	$1267.30
	Total Offering Amounts					$11,500,000		$1267.30
	Total Fees Previously Paid							—
	Total Fee Offsets							—
	Net Fee Due							$1267.30(3)

(1) Represents only the additional number of shares being registered and includes 93,750 shares of Series A common stock that the underwriters have the option to purchase. Does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1 (File No. 333-272901), as amended (the “Prior Registration Statement”).

(2) Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

(3) The registration fee is calculated in accordance with Rule 457(o) under the Securities Act based on the proposed maximum aggregate offering price. The registrant previously registered securities on the Prior Registration Statement having a proposed maximum aggregate offering price of $91,640,625, which was declared effective by the Securities and Exchange Commission on July 13, 2023. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of $11,500,000 is hereby registered, which includes shares issuable upon the exercise of the underwriters’ option to purchase additional shares.